Symbol="KNTE"
AssetType="Common Stock"
Name="Kinnate BiopharmaÂ Inc"
Description="Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers. The company is headquartered in San Diego, California."
CIK="1797768"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11975 EL CAMINO REAL, STE 101, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="149032000"
EBITDA="-125366000"
PERatio="None"
PEGRatio="None"
BookValue="4.783"
DividendPerShare="0"
DividendYield="0"
EPS="-2.56"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.266"
ReturnOnEquityTTM="-0.442"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.56"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="21.06"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.063"
EVToRevenue="-"
EVToEBITDA="-0.336"
Beta="-0.0208"
num_52WeekHigh="15.86"
num_52WeekLow="2.32"
num_50DayMovingAverage="3.503"
num_200DayMovingAverage="5.99"
SharesOutstanding="46572600"
DividendDate="None"
ExDividendDate="None"
symbol="KNTE"
open="3.07"
high="3.28"
low="3.07"
price="3.20"
volume="135044.00"
latest_trading_day="2023-07-18"
previous_close="3.07"
change="0.13"
change_percent="4.2345%"
aroon_positive_momentum_days="2"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="409697"
Change_recent_avg="-0.05"
Delta_recent_avg="0.44"
Variance_recent_avg="0.22"
Change_ratio_recent_avg="-1.51"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="1141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0174.jpeg"
image_negative_thumbnail_id_2="1166"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Negative_0187.jpeg"
image_neutral_thumbnail_id_1="568"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_neutral_thumbnail_id_2="587"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_positive_thumbnail_id_1="961"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0123.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
